The market (NASDAQ average) beta is 1, while Cronos Group's is This would suggest that Cronos Group's shares are a little bit more volatile than the. Cronos Group currently has an average brokerage recommendation (ABR) of on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual. There is currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "sell" CRON. Last Updated: Aug 29, a.m. ; Previous Close. $ ; Cronos Group Inc. stock falls Wednesday, underperforms market. Aug. 28, at p.m. ET by. Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Cronos Group is 'Hold'.
If the real value is higher than the market price, Cronos Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a. Cronos Group (CRON) reported Q1 earnings per share (EPS) of -$, meeting estimates of -$ by %. In the same quarter last year, Cronos Group's. The consensus among 2 Wall Street analysts covering (NASDAQ: CRON) stock is to Hold CRON stock. Out of 2 analysts, 0 (0%) are recommending CRON as a Strong Buy. If you simply go off of the price target and the monster gain it suggests, then things seem pretty good for CRON. But look closer and you'll see. Is Cronos Group Stock Undervalued? The current Cronos Group [CRON] share price is $ The Score for CRON is 48, which is 4% below its historic median. Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. Overall, Cronos Group Inc stock has a Value Grade of C, Growth Grade of C, Momentum Grade of B. Whether or not you should buy Cronos Group Inc stock will. Cronos Group, Inc. engages in the investment in firms which are licensed to produce and sell medical marijuana. Its portfolio includes In The Zone, Peace. Search stocks using popular investment metrics to help you sort through companies from all major U.S. equity markets. Use our Stock Screener · Use our Stock. Cronos Group is a great stock to buy right now. They have strong partnerships with major companies, they are cash rich, and insiders have been buying up shares. Cronos Group Inc stock. These are the cannabis stocks to buy as they represent companies with good fundamentals and a robust growth outlook.
Initiating coverage on Cronos stock with a "Strong Buy" rating. Cannabis industry tailwinds, conservative growth approach, and geographic expansion support. In the current month, CRON has received 2 Buy Ratings, 2 Hold Ratings, and 2 Sell Ratings. CRON average Analyst price target in the past 3 months is $ Why Cronos Group Is Plummeting Today. The marijuana stock's earnings report disappointed investors hoping for more. Cronos Group has a consensus price target of $ Q. What is the current price for Cronos Group (CRON)?. A. The stock. Cronos Group has received a consensus rating of Sell. The company's average rating score is , and is based on no buy ratings, no hold ratings. Cronos Group Inc. analyst estimates, including CRON earnings per share a Barron's Best Buy Expects Higher Profitability and the Stock Pops · Home. Is Cronos stock a Buy, Sell or Hold? Cronos stock has received a consensus rating of hold. The average rating score is and is based on 1 buy ratings. Find the latest Cronos Group Inc. (CRON) stock quote, history, news and other vital information to help you with your stock trading and investing. Is Cronos Group Inc a Good Stock to Buy? Determining whether Cronos Group Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its.
Cronos Group is forecast to grow earnings and revenue by % and % per annum respectively. EPS is expected to grow by % per annum. Return on equity is. A ratio under 40% is generally considered to be good. But note; this ratio can vary widely from industry to industry. Based on the Cronos Group stock forecast, it's now a good time to buy CRON stock because it's trading % below our forecast, and it could be undervalued. Based on 6 analysts giving stock ratings to CRON in the past 3 months. Neutral. SellBuy. Strong sellStrong buy. Strong sellSellNeutralBuyStrong buy. Strong buy. The benchmark ETFMG Alternative Harvest ETF was little moved last week, but Cronos shares are rising after it announced a new investment. CRONTLRYTCNNF.
Top 3 crypto’s to hold until 2025 #crypto #xrp #priceprediction
View analyst opinion as to whether the stock is a strong buy, strong sell or hold, based on analyst Month CRON price targets. Created with Highcharts